+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free

Diabetic Macular Edema Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

Pre Book Price: $ 5216

Original Price: $ 5795

Macular edema is the condition when the fluid and proteins start collecting on or under the macula of the eye thereby resulting in swelling.  Due to such swelling, a person’s central eye vision gets distorted. Macular edema is classified into two types namely cystoids macular edema (CME) and diabetic macular edema (DME).


Diabetic macular edema is the major reason for loss of vision in patients suffering from diabetic retinopathy. Diabetes patient are reported to have a 10% risk of developing this condition during their lifetime. On the basis of the cause of disease, DME is classified into two types:

  • Diffuse macular edema: due to abnormalities in dilated capillaries present in the retina.
  • Focal macular edema: due to abnormalities in microaneurysms

For diagnosing diabetic macular edema, an ophthalmologist checks the retina for symptoms of the disease including leaking blood vessel, retinal swelling, damaged nerve tissues and pale, fatty deposits on the retina. For further confirmation, comprehensive eye examination such as visual acuity test, dilated exam test and tonometry are performed.


During the initial stages of DME, no treatment is needed unless the patients efficiently control their blood sugar levels. If the condition becomes severe, the standard treatment for diabetic macular edema is laser photocoagulation. This procedure utilizes laser to reduce edema byapplying a pattern of burnsor bycauterizing leaky blood vessels. For avoiding the side-effects of this treatment, retinal specialists apply injections of anti-vascular endothelial growth factorcorticosteroids along with laser photocoagulation. Currently, there are only two approved drugs available in market for treating DME namely Lucentis and Ozurdex. Other treatment methods are currently under clinical trials. 


The markets for America and Europe are at the maturity stage for diabetic macular edema because large proportion of population is suffering from diabetes. Lucentis and Ozurdex ocuppy the major part of the market share in the therapeutics market. Asia-Pacific is also growing at faster pace while the markets of Africa and Australia are currently at initial stages. Some of the companies and institutes which are involved in clinical trials for treatment of diabetic macular edema are Allergan, Inc., Novartis AG, F. Hoffmann-La Roche Ltd., Regeneron Pharmaceuticals, Inc., Pfizer, Inc.,Bayer AG, Bausch & Lomb Incorporated,the Diabetic Retinopathy Clinical Research Network, The National Eye Institute, Johns Hopkins University and ShahidBeheshti University of Medical Sciences.


This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include 

  • North America 
  • Asia Pacific 
  • Europe
  • Rest of the World  

This report provides comprehensive analysis of 

  • Market growth drivers 
  • Factors limiting market growth
  • Current market trends 
  • Market structure
  • Market projections for upcoming years 

This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis. 


Reasons for Buying this Report

  • This report provides pin-point analysis for changing competitive dynamics
  • It provides a forward looking perspective on different factors driving or restraining market growth 
  • It provides a technological growth map over time to understand the industry growth rate
  • It provides a seven-year forecast assessed on the basis of how the market is predicted to grow 
  • It helps in understanding the key product segments and their future
  • It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
  • It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments 
  • It provides distinctive graphics and exemplified SWOT analysis of major market segments 

To receive discount, please click on the button below.

Please click on the button below to customize this report.

Back To Top